Financial burden after allogeneic hematopoietic cell transplantation: a qualitative analysis from the patient's perspective

Bone Marrow Transplant. 2015 Sep;50(9):1259-61. doi: 10.1038/bmt.2015.128. Epub 2015 Jun 1.

Authors

W Kim¹, J McNulty¹, Y-H Chang², M Weise³, S Hashmi⁴, S Ailawadhi⁵, N Khera³

Affiliations

¹ College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, USA.
² Division of Biostatistics, Mayo Clinic, Phoenix, AZ, USA.
³ Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
⁴ Division of Hematology/Oncology, Mayo Clinic, Rochester, MN, USA.
⁵ Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA.

PMID: 26030047
DOI: 10.1038/bmt.2015.128

No abstract available

Publication types

Letter

MeSH terms

Allografts
Cost of Illness*
Costs and Cost Analysis
Female
Hematopoietic Stem Cell Transplantation / economics*
Humans
Male
Pilot Projects
Surveys and Questionnaires*